OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Polypharmacology guided drug repositioning approach for SARS-CoV2
Esther Jamir, Himakshi Sarma, Lipsa Priyadarsinee, et al.
PLoS ONE (2023) Vol. 18, Iss. 8, pp. e0289890-e0289890
Open Access | Times Cited: 7
Esther Jamir, Himakshi Sarma, Lipsa Priyadarsinee, et al.
PLoS ONE (2023) Vol. 18, Iss. 8, pp. e0289890-e0289890
Open Access | Times Cited: 7
Showing 7 citing articles:
Advancements in the development of antivirals against SARS-Coronavirus
Mrityunjay Kumar, Mirza Sarwar Baig, Kanchan Bhardwaj
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
Mrityunjay Kumar, Mirza Sarwar Baig, Kanchan Bhardwaj
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
Medicinal polypharmacology: Exploration and exploitation of the polypharmacolome in modern drug development
Sven Marcel Stefan, Muhammad Rafehi
Drug Development Research (2023) Vol. 85, Iss. 1
Open Access | Times Cited: 14
Sven Marcel Stefan, Muhammad Rafehi
Drug Development Research (2023) Vol. 85, Iss. 1
Open Access | Times Cited: 14
Drug repurposing for neurodegenerative diseases
Halak Shukla, D. James B. St. John, Shuvomoy Banerjee, et al.
Progress in molecular biology and translational science (2024), pp. 249-319
Closed Access | Times Cited: 2
Halak Shukla, D. James B. St. John, Shuvomoy Banerjee, et al.
Progress in molecular biology and translational science (2024), pp. 249-319
Closed Access | Times Cited: 2
Molecular Property Diagnostic Suite for COVID-19 (MPDSCOVID-19): an open-source disease-specific drug discovery portal
Lipsa Priyadarsinee, Esther Jamir, Selvaraman Nagamani, et al.
Gigabyte (2024) Vol. 2024, pp. 1-17
Open Access | Times Cited: 1
Lipsa Priyadarsinee, Esther Jamir, Selvaraman Nagamani, et al.
Gigabyte (2024) Vol. 2024, pp. 1-17
Open Access | Times Cited: 1
Structure-Based Discovery of Potential HPV E6 and EBNA1 Inhibitors: Implications for Cervical Cancer Treatment
Emmanuel Broni, Carolyn Ashley, Miriam Velazquez, et al.
Computation (2024) Vol. 12, Iss. 6, pp. 112-112
Open Access
Emmanuel Broni, Carolyn Ashley, Miriam Velazquez, et al.
Computation (2024) Vol. 12, Iss. 6, pp. 112-112
Open Access
Biomarker driven drug repurposing for Fuchs’ Endothelial Corneal Dystrophy (FECD): A Computational study
Sarangthem Dinamani Singh, Gayatri Gogoi, Selvaraman Nagamani, et al.
Research Square (Research Square) (2024)
Open Access
Sarangthem Dinamani Singh, Gayatri Gogoi, Selvaraman Nagamani, et al.
Research Square (Research Square) (2024)
Open Access
Exploring bacterial metabolites in microbe-human host dialogue and their therapeutic potential in Alzheimer’s diseases
Sarangthem Dinamani Singh, Pankaj Bharali, Selvaraman Nagamani
Molecular Diversity (2024)
Closed Access
Sarangthem Dinamani Singh, Pankaj Bharali, Selvaraman Nagamani
Molecular Diversity (2024)
Closed Access
